Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

NCT04864379 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Tumor

Interventions

BIOLOGICAL: iNeo-Vac-P01
OTHER: GM-CSF
DRUG: PD-1
PROCEDURE: RFA

Sponsor

Sir Run Run Shaw Hospital

Collaborators

[object Object]